SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (29)6/2/2000 12:43:00 PM
From: scaram(o)uche   of 724
 
Very, very nice. Thanks.

Now, lessee.... if DGI can do everything that Blume indicates they can do, the upcoming IPO should be valued at about.... oh, $15 billion.

<g>

Did you notice (1) the proteomics tickler, and (2) the mention of automation/miniaturization at the end?

The IgA reference.... the author, Nina Flanagan, or editor screwed up. They refered to IGF-1 as IgF.

Antibodies on the brain.

<g>

So.... I'll write Blume, but.... still wondering what an IgA agonist for stroke could actually be?? Absolutely jazzed to see confirmation of the IGF-1 target for prostate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News